Identification of subtype-specific mutations in the genes CTNNB1 and BRAF in craniopharyngiomas could have implications for the diagnosis and treatment of patients with these brain tumours. Whole-exome sequencing identified mutations in CTNNB1 (which encodes β-catenin) in 92% of analysed adamantinomatous craniopharyngiomas, a subtype of craniopharyngiomas that is typically found in children. By contrast, all neoplasms of the papillary subtype, which is more frequent in adults, exhibited mutations in BRAF.